- Home
- OBIO vs SMHI Comparison
OBIO vs SMHI Comparison
Compare OBIO & SMHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- SMHI
- Stock Information
- Founded
- OBIO 2017
- SMHI 1989
- Country
- OBIO United States
- SMHI United States
- Employees
- OBIO N/A
- SMHI N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- SMHI Marine Transportation
- Sector
- OBIO Health Care
- SMHI Consumer Discretionary
- Exchange
- OBIO Nasdaq
- SMHI Nasdaq
- Market Cap
- OBIO 147.8M
- SMHI 150.4M
- IPO Year
- OBIO N/A
- SMHI N/A
- Fundamental
- Price
- OBIO $2.75
- SMHI $6.44
- Analyst Decision
- OBIO Strong Buy
- SMHI
- Analyst Count
- OBIO 4
- SMHI 0
- Target Price
- OBIO $14.00
- SMHI N/A
- AVG Volume (30 Days)
- OBIO 339.4K
- SMHI 76.1K
- Earning Date
- OBIO 08-12-2025
- SMHI 10-29-2025
- Dividend Yield
- OBIO N/A
- SMHI N/A
- EPS Growth
- OBIO N/A
- SMHI N/A
- EPS
- OBIO N/A
- SMHI N/A
- Revenue
- OBIO $2,944,000.00
- SMHI $255,033,000.00
- Revenue This Year
- OBIO $19.83
- SMHI N/A
- Revenue Next Year
- OBIO $12.53
- SMHI $9.97
- P/E Ratio
- OBIO N/A
- SMHI N/A
- Revenue Growth
- OBIO 41.61
- SMHI N/A
- 52 Week Low
- OBIO $2.37
- SMHI $3.63
- 52 Week High
- OBIO $6.50
- SMHI $10.59
- Technical
- Relative Strength Index (RSI)
- OBIO 50.09
- SMHI 56.64
- Support Level
- OBIO $2.65
- SMHI $6.23
- Resistance Level
- OBIO $3.08
- SMHI $6.99
- Average True Range (ATR)
- OBIO 0.16
- SMHI 0.28
- MACD
- OBIO 0.03
- SMHI -0.01
- Stochastic Oscillator
- OBIO 52.86
- SMHI 44.44
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.